1. Home
  2. Stocks
  3. Sotac Share Price

Sotac Pharmaceuticals Ltd Share Price

Pharmaceuticals Small Cap

₹128.00 +6 (4.92%)

09 Nov, 2024 11:58

SIP TrendupStart SIP in SOTAC

Start SIP
Performance Financial Technical Events FnO Shareholding Pattern More FAQ’s

Performance

  • Low
  • ₹122
  • High
  • ₹128
  • 52 Week Low
  • ₹87
  • 52 Week High
  • ₹203
  • Open Price₹122
  • Previous Close₹122
  • Volume3,600

Investment Returns

  • Over 1 Month -2.07%
  • Over 3 Month -17.53%
  • Over 6 Month + 1.59%
  • Over 1 Year + 9.97%
SIP Lightning

Smart Investing Starts Here Start SIP with Sotac Pharmaceuticals Ltd for Steady Growth!

Invest Now

Sotac Pharmaceuticals Ltd Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 31.7
  • PEG Ratio
  • Market Cap Cr
  • 141
  • P/B Ratio
  • 2.9
  • Average True Range
  • 5.4
  • EPS
  • 4.16
  • Dividend Yield
  • 0
  • MACD Signal
  • -5.83
  • RSI
  • 44.45
  • MFI
  • 32

Sotac Pharmaceuticals Ltd Financial

IndicatorJun 24Mar 24Dec 23Sep 23Jun 23
Net Sales/Income from operations13.0116.3117.6814.2018.91
Total Income From Operations13.0116.3117.6814.2018.91
P/L Before Interest, Excpt. Items & Tax1.932.112.522.342.03
P/L Before Exceptional Items & Tax1.671.862.292.151.69
P/L After Tax from Ordinary Activities1.261.381.731.671.21
Net Profit/Loss For the Period1.261.381.491.671.21
IndicatorMar 24Mar 23
Revenue From Operations [Gross]67.1157.98
Revenue From Operations [Net]67.1157.98
Total Operating Revenues67.1157.98
Total Revenue68.4258.23
Total Expenses60.4352.26
Profit/Loss Before Tax7.765.96
Profit/Loss For The Period5.754.50
IndicatorMar 24Mar 23
Net CashFlow - Operating Activity-19.798.54
Net Cash Used In Investing Activity-12.53-10.93
Net Cash Used in Finance Activity23.3611.97
Net Inc/Dec In Cash And Equivalent-8.969.57
Cash And Equivalent End Of Year0.649.60
IndicatorMar 24Mar 23
Total Share Capital11.058.05
Total Non-Current Liabilities4.536.68
Total Current Liabilities23.2827.11
Total Capital And Liabilities76.0954.78
Total Non-Current Assets29.3418.18
Total Current Assets46.7536.61
Total Assets76.0954.78
Indicator20242023
EBIT Margin (%)13.4111.77
Return On Capital Employed (%)17.0424.66
Return On Equity (%)11.9039.02
Long Term Debt To Equity (%)9.1357.23
Book Value/Share (INR)43.6914.31
IndicatorSep 24Jun 24Mar 24Dec 23Sep 23
Net Sales/Income from operations27.3525.2526.4525.7426.67
Total Income From Operations27.3525.2526.4525.7426.67
P/L Before Interest, Excpt. Items & Tax1.821.720.112.691.14
P/L Before Exceptional Items & Tax1.221.300.301.710.69
P/L After Tax from Ordinary Activities0.421.351.740.880.21
Net Profit/Loss For the Period0.421.351.510.880.21
IndicatorMar 24Mar 23
Revenue From Operations [Gross]103.8377.48
Revenue From Operations [Net]103.8377.48
Total Operating Revenues103.8377.48
Total Revenue104.3277.83
Total Expenses100.1274.49
Profit/Loss Before Tax3.963.93
Profit/Loss For The Period3.582.29
IndicatorMar 24Mar 23
Net CashFlow - Operating Activity-16.128.14
Net Cash Used In Investing Activity-19.68-11.67
Net Cash Used in Finance Activity29.5413.14
Net Inc/Dec In Cash And Equivalent-6.269.61
Cash And Equivalent End Of Year3.429.68
IndicatorMar 24Mar 23
Total Share Capital11.058.05
Total Non-Current Liabilities12.278.14
Total Current Liabilities43.7345.81
Total Capital And Liabilities105.3373.64
Total Non-Current Assets44.6826.50
Total Current Assets60.6547.14
Total Assets105.3373.64
Indicator20242023
EBIT Margin (%)5.686.86
Return On Capital Employed (%)9.5819.12
Return On Equity (%)7.9022.88
Long Term Debt To Equity (%)26.8077.77
Book Value/Share (INR)44.6412.69

Sotac Pharmaceuticals Ltd Technicals

EMA & SMA

Current Price
₹128.00
+ 6 (4.92%)
pointer
  • stock-down_img
  • Bullish Moving Average 3
  • stock-up_img
  • Bearish Moving Average 13
  • 20 Day
  • ₹132.52
  • 50 Day
  • ₹139.11
  • 100 Day
  • ₹138.18
  • 200 Day
  • ₹133.63

Resistance and Support

126 Pivot Speed
  • R3 136.00
  • R2 132.00
  • R1 130.00
  • S1 124.00
  • S2 120.00
  • S3 118.00

Is Sotac Pharmaceuticals Ltd Worth Buying?

BUY SELL HOLD

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Sotac Pharmaceuticals Ltd has an operating revenue of Rs. 104.78 Cr. on a trailing 12-month basis. An annual revenue growth of 34% is outstanding, Pre-tax margin of 4% needs improvement, ROE of 7% is fair but needs improvement. The company has a reasonable debt to equity of 27%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 97 which is a GREAT score indicating consistency in earnings, a RS Rating of 18 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D+ which indicates heavy supply, Group Rank of 100 indicates it belongs to a poor industry group of Medical-Biomed/Biotech and a Master Score of C is fair but needs to improve. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

 (+)

Sotac Pharmaceuticals Ltd Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-10-29 Quarterly Results
2024-08-13 Quarterly Results
2024-05-17 Audited Results & Others To consider other business matters
2023-11-06 Quarterly Results
2023-05-29 Audited Results

Sotac Pharmaceuticals Ltd F&O

Sotac Pharmaceuticals Ltd Shareholding Pattern

72.85%
8.88%
6.01%
12.26%
  • NSE Symbol
  • SOTAC
  • BSE Symbol
  • Chairman & Managing Director
  • Mr. Sharadkumar Dashrathbhai Patel
  • ISIN
  • INE0O2D01012

Similar Stocks to Sotac Pharmaceuticals Ltd

Sotac Pharmaceuticals Ltd FAQs

Sotac Pharmaceuticals Ltd share price is ₹128 As on 09 November, 2024 | 11:44

The Market Cap of Sotac Pharmaceuticals Ltd is ₹141.4 Cr As on 09 November, 2024 | 11:44

The P/E ratio of Sotac Pharmaceuticals Ltd is 31.7 As on 09 November, 2024 | 11:44

The PB ratio of Sotac Pharmaceuticals Ltd is 2.9 As on 09 November, 2024 | 11:44

Q2FY23
Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91
 
footer_form

The Vigilance Awareness Week for the year 2024 (VAW 2024) would be observed from October 28, 2024 to November 03, 2024
“सत्यनिष्ठा की संस्कृनि सेराष्र की समद्ृधि” “Culture of Integrity for Nation's Prosperity”
e-pledge link (https://pledge.cvc.nic.in/)

5paisa Capital Ltd. CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI-registered Mutual Fund Distributor | AMFI REGN No.: ARN-104096 | Date of initial Registration: 30/07/2015 | Current validity of ARN : 30/07/2027 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

*Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of ₹10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

Contact Us

Attention Investors

  • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
  • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
  • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

Email: support@5paisa.com

Support Desk Helpline: 8976689766

©2024, 5paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.